Similar results were obtained for gliomas where the degree of LACTB downregulation correlated with an unfavourable overall clinical outcome, and in glioma cell lines LACTB overexpression resulted in an inhibition of cell proliferation [26]. Here, LACTB is linked to central nervous system cancer.